Leveraging connections for positive change

Our team is applying the tools of causal inference and network science to address critical public health and education challenges.

Overview

Our team is applying the tools of causal inference and network science to address some of the most pressing public health and educational challenges, such as harm reduction measures among people who use drugs, increasing pre-exposure prophylaxis uptake among men who have sex with men, and improving learning in statistics education. We recognize in these contexts that shared influence between patients, students and participants must be considered when evaluating interventions with possible dissemination. 

Our research team is supported by the Avenir Award from the National Institute on Drug Abuse (DP2DA046856). The goal of this project is to develop causal inference methodology combined in novel ways with network science to solve critical challenges at the nexus of HIV and substance use for network-based studies of HIV treatment and prevention among People Who Use Drugs (PWUD). This project aims to advance HIV prevention and treatment research by contributing new methodology to study causal mechanisms in networks of people who use drugs at high risk for HIV infection. 

For substantive work in statistics education research, we evaluated peer collaborations among statistics students in two undergraduate courses at the University of Rhode Island. The primary tools include network-based visualization, characterization, and modeling methods including Exponential Random Graph Models (ERGMs). The results from this study can provide data-driven approaches to improve statistics pedagogy to engage students successfully.

 

Team

We are the Networks and Causal Inference for Public Health and Education Research team at the University of Rhode Island. Our research involves statistical methods development combining causal inference and network analysis approaches to address high priority questions in public health and education.

Team Members

Current team members

Associate Professor

Pharmacy Practice, College of Pharmacy

401.874.4739
buchanan at uri dot edu

Director, Data Science and Associate Professor

Dept. of Computer Science and Statistics

nkatenka@cs.uri.edu

Graduate Chair, Statistics and Associate Professor

Dept. of Computer Science and Statistics

jing_wu@uri.edu

Graduate Research Assistant

Dept. of Computer Science and Statistics

ryan_humphreys@uri.edu

Research Associate/Data Analyst

College of Pharmacy

gabrielle.lemire@uri.edu

Graduate Research Assistant

Dept. of Computer Science and Statistics

kzhang@uri.edu

Past team members

NIDA Diversity Post Doctoral Fellow

Dept. of Computer Science and Statistics

haroke@uri.edu

Post Doctoral Fellow

tingfanglee@uri.edu

Graduate Research Assistant

Dept. of Computer Science and Statistics

jpuleo@uri.edu

Graduate Research Assistant

vmryan@uri.edu

Graduate Research Assistant

Dept. of Computer Science and Statistics

Ayako.Shimada@jefferson.edu

Graduate Student/Research Assistant

Pharmacy Practice, College of Pharmacy

benben1113@uri.edu

PhD Graduate/Research Assistant

Pharmacy Practice, College of Pharmacy

tysun@uri.edu

Graduate Student/Research Assistant

Pharmacy Practice, College of Pharmacy

raviupadhyay@uri.edu

Collaborators

Assistant Professor of Biostatistics on the Teaching Scholar Track

Brown University

Founding Director of the People, Place & Health Collective (PPHC), and Professor of Epidemiology

Brown University School of Public Health

Vice Chair, Department of Health, Behavior, and Society Professor

John Hopkins Bloomberg School of Public Health

Susan Dwight Bliss Professor of Biostatistics; Professor, Department of Statistics and Data Science; Founding Director, Center for Methods in Implementation and Prevention Science (CMIPS); Director, Interdisciplinary Research Methods Core, Center for Interdisciplinary Research on AIDS (CIRA); Assistant Director, Global Oncology, Yale Cancer Center; Affiliated Faculty, Yale Institute for Global Health

Yale School of Public Health

Assistant Professor in Epidemiology

Boston University School of Public Health

Professor and Head of Biostatistics, Bioinformatics and Epidemiology Program Vaccine and Infectious Disease Division, and Professor Public Health Sciences Division

Fred Hutch Cancer Center

Associate Professor in Biostatistics

John Hopkins Bloomberg School of Public Health

Associate Professor of Biostatistics, Associate Professor of Ecology and Evolutionary Biology, Associate Professor of Management, and Associate Professor of Statistics and Data Science; Co-director, Public Health Modeling Concentration

Yale School of Public Health

Assistant Professor of Epidemiology and Public Health at the Medical School

Medical School, University of Cyprus, Nicosia, Cyprus

Researcher

Medical School, University of Cyprus, Nicosia, Cyprus

Professor of Statistics

Department of Mathematics & Statistics, University of Cyprus

Assistant Professor of Biostatistics

Yale Institute for Global Health

Assistant Professor

Université du Québec à Montréal (UQUAM)

Associate Professor Community Health and Social Sciences

City University of New York School of Public Health

Research Scientist in Biostatistics; Associate Director, Interdisciplinary Research Methods Core, Center for Interdisciplinary Research on AIDS; Affiliated Faculty, Yale Institute for Global Health

Center for Methods in Implementation and Prevention Science, Yale School of Public Health

Senior Theoretician and Associate Director of the Infectious Disease Epidemiology and Theory Core at the Center for Drug Use and HIV Research (CDUHR), and Research Professor, Department of Population Health

Center for Opioid Epidemiology and Policy in the Department of Population Health at NYU Grossman School of Medicine

Professor

College of Pharmacy, URI

Manning Assistant Professor of Biostatistics

Brown University

Acknowledgments and Funding

University of Rhode Island Proposal Development Grant 2018-2019
This grant provides support for the development of future proposals by URI faculty.

NIH grant DP2DA046856
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)

NIH Diversity Postdoctoral Fellowship (DP2 DA046856)

News

  • 2019 JSM Conference Presentation

    Dr. Ashley Buchanan presented at Joint Statistical Meetings (JSM) 2019 as a part of the “Novel Statistical Methods for Network-Based Studies Among People Who Use Drugs” session. Her talk was titled “Toward Evaluation of Dissemination of HIV Prevention Interventions Among Networks of People Who Inject Drugs” and covers research on the application of cluster based disseminated effects methods to networked data. It included results from an analysis on the effects of individual attitudes towards HIV risk on engagement with HIV care among people who inject drugs (PWID) from the Social Factors and HIV Risk study.

    JSM Talk 2019 v5

  • 2019 Speaker at UW Biostatistics Seminar

    Dr. Ashley Buchanan presented at the Biostatistics Seminar at the University of Washington (UW) in 2019 on some of our research regarding the effect of injection partner beliefs on health seeking behavior.

    UW Biostatistics Seminar 2019

  • 2020 Congratulations!

    Congratulations to our recent graduates! Ben Skov graduated with a Master of Science in Pharmaceutical Science. Ben’s thesis is titled Evaluation of the Relationship between Centrality and Individual-Level Characteristics among PWID. Joseph Puleo graduated with a Master of Science in Statistics (2020). Joseph’s thesis is titled Evaluating the Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors Among a Network of People Who Inject Drugs. Joseph’s current job is as a Biostatistician I at the Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health. Valerie Ryan graduated with a Doctor of Philosophy in Behavior Science, Master of Science in Statistics, and Master of Arts in Behavior Science (2020). Valerie’s thesis title is Graph Models with Missing Data Techniques for Applications in Drug Use Networks. Valerie is now a Behavior Scientist at the National Center for Health Statistics.

  • 2020 ENAR Conference Presentation

    Dr. Buchanan presented “Toward Evaluation of Disseminated Effects of Non-Randomized HIV Prevention Interventions Among Observed Networks of PWID” at the Eastern North American Region International Biometric Society 2020 conference. She presents a novel method for estimation of disseminated effects among members of a network as well as approaches to bootstrap estimation of the variance of the novel estimator.

    ENAR_2020-v4.pdf

  • 2021 Congratulations!

    Congratulations to Dr. Tingfang Lee on completing her post-doctoral work as part of the Avenir team! In her role, she built novel methods and statistical models to assess the impact of interventions and risk factors on individuals embedded in networks, specifically those pertaining to HIV and illicit drug use. Congratulations to Dr. Hilary Aroke on completing his post-doctoral work as a part of the Avenir team! Aroke was awarded the prestigious National Institute on Drug Abuse (NIDA) Diversity Post Doctoral Fellowship. During the past 2-3 years he has conducted epidemiologic and network science research using a variety of data sources. His current interest is in substance abuse research. Congratulations to Dr. Tianyu Sun on completing his PhD. His thesis title is “Evaluation of Medications for Opioid Use Disorder on Overdose and Healthcare Utilization in the US.”

  • 2021 Guest Appearance on Causal Inference Podcast

    Dr Ashley Buchanan appeared as a guest on season 3 of the podcast Casual Inference. She discusses the importance of correctly estimating causal effects in dependent data structures, such as networks. Fun fact, this is how our Research Associate, Gabrielle Lemire, heard of the Avenir team!   

    You can find the episode here, or take a listen below:

     

  • 2021 Invited Speaker at NYU Seminar

    Dr. Ashley Buchanan was an invited speaker at the Biostatistics Seminar at New York University in October 2021 on “Estimating Causal Effects of Non-Randomized HIV Prevention Interventions with Spillover in Network-based Studies among People who Inject Drugs”.

  • 2021 JSM Sessions and Presentations

    Dr. TingFang Lee (Postdoctoral Fellow) organized a topic contributed session that was accepted through a competitive process at the American Statistical Association Joint Statistical Meetings (JSM) in August 2021. This symposium was titled “Evaluating Causal Effects Using Incomplete Data with Interference in Public Health Research” and brought together leading researchers in this area, including Drs. Costanza Tortù, Imke Mayer, TingFang Lee, and Junhan Fang. Dr. Samrachana Adhikari from the New York School of Medicine served as the Discussant.

    Dr. Lee presented work on evaluating the impact of missing data when assessing dissemination titled “Evaluating Disseminated Effects of Incomplete Data in Network-Based Studies for Public Health”.

    Hilary Aroke also presented “Novel Application of a Multistate Model to Investigate the Opioid Use Disorder Care Cascase in Rhode Island” at JSM 2021. This presentation was as a part of the session “Innovative Methods for Predicting Public Health Outcomes and Informing Policy” which was organized by Dr. Ashley Buchanan.

  • 2021 NESS Session and Presentations

    In August 2021, Dr. Buchanan organized an invited session at the New England Statistical Society (NESS) symposium titled “Novel statistical approaches for public health and education studies with clustering and network features”. This session highlighted key work from the URI Avenir team and collaborators.

    Dr. Youjin Lee presented “Partially Pooled Propensity Score Models for Average Treatment Effect Estimation with Multilevel Data”. Dr. Hilary Aroke presented “Novel Application of a Multistate Model to Investigate the Opioid Use Disorder Care Cascade among Medicaid Enrollees in Rhode Island”. Dr. TingFang Lee presented “Toward Evaluation of Disseminated Effects of Non-Randomized HIV Prevention Interventions Among Observed Networks of People who Inject Drugs”. Dr. Ashley Buchanan presented “Spillover of Pre-Exposure Prophylaxis for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model”.

  • 2021 Welcome!

    In 2021, we welcomed a new collaborator to our team, Dr. Youjin Lee from Brown University, an expert in network dependence. We also expanded collaborations across institutions to include Boston University (with site PI Dr. Eleanor Murray, an expert in causal agent-based models), and University of Cyprus (with site PI Dr. Georgios Nikolopoulos).

  • 2022 BU Workshop Presentation and Tutorial

    Dr. Murray and Dr. Buchanan presented at a workshop on simulation modeling for causal inference “Incorporating Causal Inference into Simulation Models.” The workshop included presentations on the estimation of causal effects in network models. Dr. Buchanan also developed and delivered a tutorial on spillover in agent based models (ABM) as part of this workshop, titled “Adding complexity: How to think about causal effects in systems models with interference or transmission”.

    This workshop was hosted in conjunction with the Focused Research Program group at the Rafik B. Hariri Institute for Computing and Computational Science and Engineering at Boston University in April 2022.

  • 2022 ENAR Spring Conference Presentations on Eliminating Health Disparities

    In March 2022, Dr. Aroke organized an invited session that was accepted through a competitive process at the Eastern North American Region International Biometric Society 2022 Spring Meeting. The title of the session was “Novel Data Science Approaches to Eliminate Health Disparities”. The speakers included Drs. Natallia Katenka, Anarina Murillo, and Hilary Aroke.

    Dr. Aroke presented work titled “Novel Application of a Multistate Model to Investigate Disparities in Access to Treatment for Opioid Use Disorder in Rhode Island”.

    Dr. Natallia Katenka presented “New Approaches to Model Multi-level Social Networks for Evaluating the Impact of Demographics on Health Disparities of Epidemic Trajectories in the NYC Population” at the Eastern North American Region International Biometric Society 2022 Spring Meeting in March 2022.

    https://www.enar.org/meetings/spring2022/

  • 2022 International Symposium on Mathematical Methods Applied to the Sciences Conference Presentation

    In February 2022, Dr. Anarina Murillo delivered a presentation titled “Novel Application of a Multistate Model to Evaluate the Opioid Use Disorder Care Cascade in the Rhode Island All-Payer Claims Database” at the International Symposium on Mathematical Methods Applied to the Sciences, SIMMAC XXIII.

    https://eventos.cimpa.ucr.ac.cr/index.php/simmac/XXIIISIMMAC

  • 2022 Invited Speaker at BU Seminar

    Dr. Ashley Buchanan was an invited speaker at the Causal Inference Seminar Boston University in April 2022 to speak on “Estimating Causal Effects of Non-Randomized HIV Prevention Interventions with Spillover in Network-based Studies among People who Inject Drugs”.

  • 2022 JSM Sessions and Presentations

    Dr. Youjin Lee organized the invited session “Advances in Social Network Analysis for Public Health Solutions” at 2022 Joint Statistical Meetings (JSM) titled “Advances in Social Network Analysis for Public Health Solutions,” with Gabrielle Lemire as discussant and Dr. Natallia Katenka as an invited speaker. Dr. Katenka’s talk is titled “New Approaches to Model Multi-Level Social Networks for Evaluating the Impact of Demographics on Health Disparities of Epidemic Trajectories in the NYC Population.”

    Gabrielle Lemire also presented “Bias Correction for Sampled Genetic Network Data” as a part of the Bayesian Methods and Social Statistics Speed Session.

  • 2022 Paper Accepted

    Congratulations to Dr. Buchanan et al. whose paper “Spillover effects of pre-exposure prophylaxis delivery for HIV prevention: Evaluating the importance of effect modification using an agent-based model” has been accepted in the journal of Epidemiology and Infection.

    Buchanan AL, Park, CJ, Bessey S, Goedel WC, Murray EJ, Friedman SR, Halloran ME, Katenka NV, Marshall BDL. Spillover effects of pre-exposure prophylaxis delivery for HIV prevention: Evaluating the importance of effect modification using an agent-based model. Epidemiology and Infection. In Press, 2022.

  • 2022 Presentation at 9th Annual ASA Workshop

    In October 2022, Dr. Natallia Katenka presented “Causal Inference in Networks with Applications in Public Health” at the 9th Annual ASA New Jersey Chapter and Bayer Statistics and Data Insights workshop.

  • 2022 Presentation at CMIPS and MSU

    In December 2022, Gabrielle Lemire presented Simulating Potential Outcomes in the Presence of Interference” at Center for Methods in Implementation and Prevention Science (CMIPS) at the Yale School of Public Health and for the Student Chapter of the American Statistical Association (ASA) at Montana State University (MSU). Congrats!

  • 2022 Student Presentations at URI Conference

    Congratulations to graduate students Ke Zhang, Ryan Humphreys and Zhejia Dong who presented at the research conference “Advancing Data Analysis in Interdisciplinary Studies: Deciphering the World’s Black Boxes” on October 21, 2022 at the University of Rhode Island (URI) in collaboration with the HAW Hamburg. An additional thanks to Dr Katenka for co-leading and co-facilitating the conference.

  • 2022 Uni of Pittsburgh Presentation

    In February 2022, Dr. Natallia Katenka presented “Estimating Causal Effects of Non-Randomized HIV Prevention Interventions with Spillover in Network-based Studies among People who Inject Drugs” for the Department of Statistics at the University of Pittsburgh, PN.

  • 2023 “Causal Inference in Networks” Virtual Spring Workshop

    Congratulations to Dr. Ashley Buchanan, Ke Zhang, and Gabrielle Lemire who presented during the Lightnight Talks, and ran a code demo, at  “Causal Inference in Networks: Applications to Public Health” Spring Virtual Workshop in March 2023. Thank you to the other speakers who also presented: Drs. Laura Forastiere, Samrachana Adhikari, and Elizabeth Ogburn. We had over 100 individuals register and attendees were from all over the globe!

  • 2023 American Causal Inference Conference (ACIC) Poster Presentation

    Congratulations to Gabrielle Lemire for presenting the poster “Simulating Potential Outcomes in the Presence of Interference” at ACIC in May 2023.

  • 2023 CUNY Presentation on RDS

    In January 2023, Gabrielle Lemire presented “Regression Methods for Respondent Driven Samples (RDS): An Application to Young Adults Using Presciption Opioids Non-Medically in NYC” for the Institute for Implementation Science in Population Health (ISPH) at City University of New York (CUNY). You can find more information here.

  • 2023 Johns Hopkins University Presentation

    Congratulations to Dr. Natallia Katenka for her presentation “Power and sample size calculations for evaluating spillover effects in networks with non-randomized interventions” at the Department of Biostatistics, Johns Hopkins University, Baltimore, MD in February 2023!

  • 2023 NESS Presentation

    Congratulations to Dr. Natallia Katenka for her presentation “Power and sample size calculations for evaluating spillover effects in networks with non-randomized interventions” at the New England Statistical Symposium (NESS), Boston, MA in June 2023!

  • 2023 Pathogens Paper!

    Congratulations to Dr. Ashley Buchanan et. al. whose paper Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs was accepted in the journal Pathogens and published in February 2023.

     

     

     

  • 2023 Presentation at IBS

    Congratulations to Dr. Youjin Lee for presenting about the paper, “Finding influential subjects in a network using a causal framework,” at the International Biometric Society (IBS) Journal Club in April 2023!

Research

Shared Resources

Join Us

URI Avenir

  • URI Avenir (NIDA DP2)

    Our research team is supported by the Avenir Award from the National Institute on Drug Abuse (#1DP2DA046856-01). The goal of this project is to develop causal inference methodology combined in novel ways with network science to solve critical challenges at the nexus of HIV and substance use for network-based studies of HIV treatment and prevention among People Who Use Drugs (PWUD). This project aims to advance HIV prevention and treatment research by contributing new methodology to study causal mechanisms in networks of people who use drugs at high risk for HIV infection. Limited methodological research has been done to quantify causal individual, disseminated and composite effects in non-randomized or observational settings using agent based models (ABMs) and network science approaches. In studies with more general forms of dissemination (e.g., between networks), the causal effect of interest can be difficult to identify. Claims of causality are further complicated by such issues as homophily, i.e., similar individuals tend to be connected, and confounding both at the individual- and network-levels. Without these developments, we cannot quantify the full impact of interventions on the determinants of HIV risk and the HIV care continuum among PWUD networks.